ArticleJCO oncology practice2022
Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center.
Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Trial
- Patterns of exclusive, dual and poly tobacco products use among cancer survivors in the United States.Journal of cancer survivorship : research and practice · 2025Article
- Specialty Tobacco Treatment Implementation in Oncology: A Qualitative Study.JCO oncology practice · 2025Article
- Motivating smoking cessation among patients with cancers not perceived as smoking-related: a targeted intervention.Cancer causes & control : CCC · 2025Article
- Rural and Appalachian cancer survivors' responses to tobacco use screening and tobacco treatment offer.Tobacco induced diseases · 2025Article
- Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providers.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2025Article
- Understanding cancer patients' desire to quit tobacco without assistance: A mixed-methods study.Journal of health psychology · 2024Article
- Article
- The Natural Trajectory of Smoking Cessation Among Cancer Patients Who Want to Quit "On Their Own": A Mixed-Methods, Longitudinal Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Article
- Article
- Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer Patients.Yonsei medical journal · 2023Article
- Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors.Scientific reports · 2023Article
- A Daily Assessment Study of Smoking Cessation After a Head and Neck Cancer Diagnosis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- Changes in Cigarette Smoking Behavior in Cancer Survivors During Diagnosis and Treatment.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- The Tobacco Endgame-A New Paradigm for Smoking Cessation in Cancer Clinics.Current oncology (Toronto, Ont.) · 2022Review
- Article
- Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.Current oncology (Toronto, Ont.) · 2022Article
- Tragic Triad of Tobacco Dependence, Cancer, and COVID-19 Pandemic: An Urgent Call for Attention by Health Care Systems and Professionals.JCO oncology practice · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeSmoking after a cancer diagnosis is linked to cancer-specific and all-cause mortality, among other adverse outcomes. Yet, 10%-20% of US cancer survivors are current smokers. Implementation of evidence-based tobacco treatment in cancer care facilities is widely recommended, yet rarely accomplished. This study focuses on the early outcomes of a population-based tobacco treatment program integrated within an National Cancer Institute-designated cancer center. METHODS AND MATERIALS: The sample consists of 26,365 patients seen at the cancer center during the first 18 months of program implementation. The study is a retrospective chart review of patients' tobacco use and, among current users, patients' treatment referral response.
resultsMore than 99% of patients were screened for tobacco use. Current (past month) use was observed in 21.05% of patients; cigarettes were the most popular product. Only 17.22% of current users accepted a referral for tobacco treatment; among current users who declined, the majority were not ready to quit (65.84%) or wanted to quit on their own (27.01%). Multiple demographic variables were associated with tobacco use and treatment referral response outcomes.
conclusionDespite cancer diagnosis presenting a teachable moment for tobacco cessation, patients with cancer may not be ready to quit or engage with treatment. Clinically proven strategies to increase motivation, prompt quit attempts, and encourage treatment use should be key components of tobacco treatment delivery to patients with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.